Award
National Institute of Allergy and Infectious Diseases 5U01AI172853-04
Development of a Novel Therapeutic for Mitigating Radiation-Induced Microbiome Dysbiosis and Acute Gastrointestinal Syndrome
Recipient
Columbia University Health Sciences
Award Amount
$495,545.00
Ceiling
$495,545.00
Awarded
January 09, 2026
Identifier
5U01AI172853-04
NIH awarded Columbia University $495,545 to develop MIIST305, a novel therapeutic to counteract radiation-induced gastrointestinal syndrome by preserving gut microbiota and reducing inflammation, addressing a critical need for FDA-approved radiation GI injury treatments.
Description
Development of a novel GI-targeted therapeutic drug (MIIST305) to mitigate radiation-induced gastrointestinal injury by maintaining gut microbiota balance and reducing inflammation, aiming to develop an FDA-approved medical countermeasure for radiation public health emergencies.